Literature DB >> 11991881

Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma.

Sukhbir K Shahid1, Sergei A Kharitonov, Nicola M Wilson, Andrew Bush, Peter J Barnes.   

Abstract

Exhaled breath condensate analysis for noninvasive quantification of airway inflammation in asthma is a potentially useful research tool in children. There is an imbalance between T-helper (Th)-2 cells, which secrete interleukin (IL)-4, and Th1 cells, which secrete interferon (IFN)-gamma, in asthma. We measured concentrations of IL-4 and IFN-gamma in breath condensates of 37 children (11 normal, 12 steroid-naive, and 14 steroid-treated children with asthma). Exhaled IFN-gamma was significantly lower in steroid-naive and steroid-treated children with asthma compared with normal control subjects (3.7 +/- 0.2 versus 5.1 +/- 0.4 pg/ml, p < 0.01 and 4.1 versus 5.1 pg/ml, p < 0.05). By contrast, mean exhaled IL-4 was elevated in asthma (53.7 +/- 4.2 pg/ml) compared with normal children (35.7 +/- 6.2 pg/ml, p < 0.05) and concentrations were lower with steroid treatment (37.5 +/- 5.6 pg/ml, p < 0.05). Exhaled IL-4 was significantly lower in children with asthma on more than 600 microg inhaled steroid/day. The IL-4/IFN-gamma ratio was significantly greater in children with asthma compared with control children and the children with asthma on inhaled steroid therapy. We have shown for the first time that IFN-gamma and IL-4 can be assayed in exhaled breath condensate and shows an increased ratio of IL-4/IFN-gamma, consistent with predominance of Th2 cells in airways of children with asthma. Exhaled breath condensate analysis may have a useful role in studying allergic inflammation in childhood asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991881     DOI: 10.1164/rccm.2108082

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  Exhaled breath condensate: an overview.

Authors:  John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2007-11       Impact factor: 3.479

Review 2.  Are exhaled breath condensates useful in monitoring asthma?

Authors:  Fanny W S Ko; T F Leung; David S C Hui
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

Review 3.  Exhaled breath condensate: an overview.

Authors:  Michael D Davis; Alison Montpetit; John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2012-07-20       Impact factor: 3.479

4.  Measured Pulmonary and Systemic Markers of Inflammation and Oxidative Stress Following Wildland Firefighter Simulations.

Authors:  Matthew D Ferguson; Erin O Semmens; Charles Dumke; John C Quindry; Tony J Ward
Journal:  J Occup Environ Med       Date:  2016-04       Impact factor: 2.162

5.  Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects.

Authors:  Patricia Fabian; Joseph Brain; E Andres Houseman; James Gern; Donald K Milton
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-01       Impact factor: 2.849

Review 6.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

7.  Interleukin-4 -589C/T Polymorphism is Associated with Increased Pediatric Asthma Risk: A Meta-Analysis.

Authors:  Suqin Zhang; Yuqin Li; Yufeng Liu
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

8.  Possible impact of salivary influence on cytokine analysis in exhaled breath condensate.

Authors:  T Ichikawa; K Matsunaga; Y Minakata; S Yanagisawa; K Ueshima; K Akamatsu; T Hirano; M Nakanishi; H Sugiura; T Yamagata; M Ichinose
Journal:  Anal Chem Insights       Date:  2007-10-12

Review 9.  The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Authors:  Sergio Romagnani
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Exhaled breath condensate: a promising source for biomarkers of lung disease.

Authors:  Yan Liang; Samantha M Yeligar; Lou Ann S Brown
Journal:  ScientificWorldJournal       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.